<DOC>
	<DOCNO>NCT00896233</DOCNO>
	<brief_summary>This study assess repeatability Magnetic Resonance Elastography ( MRE ) healthy volunteer Hepatitis C Virus ( HCV ) -infected patient fibrosis lay groundwork validation MRE alternative liver biopsy .</brief_summary>
	<brief_title>Magnetic Resonance Elastography Assessment Liver Fibrosis ( MK-0000-132 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<criteria>Male female least 18 year age Generally good health Willing fast 8 hour prior study visit Hepatitis C Virus ( HCV ) Positive serology HCV detectable HCV ribonucleic acid ( RNA ) blood within 12 week screening ; For Part I , know fibrosis stage least =F2 ( METAVIR ) =F3 ( Ishak ) biopsy perform within 3 month screen ; For Part 2 , know fibrosis stage F1F4 ( METAVIR ) F1F6 ( Ishak ) Never treat HCV Healthy Participant Documented absence hepatitis B virus , HCV , acute hepatitis A virus , human immunodeficiency virus ( HIV ) within 12 week screen History stroke , seizure , neurological disorder Consumption excessive amount alcohol Use product contain nicotine Unable hold breath 20 second Claustrophobia Use illicit drug history drug alcohol abuse HCVPositive Evidence history chronic hepatitis cause HCV HIV</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Staging liver fibrosis prior clinical trial treatment Hepatitis C Virus</keyword>
</DOC>